Biomarin Pharmaceutical Stock Widgets and Gadgets
BMRN Stock | USD 88.61 0.87 0.99% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- BMRN Biomarin Pharmaceutical
- Latest CORRECTING and REPLACING Jean-Jacques Bienaim Appointed Chairman of the Board at Owkin
- BMRN 88.61 0.87
- Low 87.92
- High 88.74
- Volume 1 M
- Alpha -0.067
- Beta -0.13
- Return On Equity 0.0351
- Return On Asset 0.0163
- Profit Margin 0.07 %
- Operating Margin 0.04 %
- Current Valuation 16.35 B
- Shares Outstanding 188.68 M
- Shares Owned By Insiders 0.67 %
- Shares Owned By Institutions 99.33 %
- Number Of Shares Shorted 3.06 M
- Price To Earning 220.73 X
- Price To Book 3.30 X
- Price To Sales 6.75 X
- Revenue 2.42 B
- Gross Profit 1.61 B
- EBITDA 261.98 M
- Net Income 167.65 M
- Cash And Equivalents 1.27 B
- Cash Per Share 6.85 X
- Total Debt 1.13 B
- Debt To Equity 0.24 %
- Current Ratio 5.15 X
- Book Value Per Share 26.25 X
- Cash Flow From Operations 159.26 M
- Short Ratio 1.96 X
- Earnings Per Share 0.87 X
- Price To Earnings To Growth 0.71 X
- Target Price 109.48
- Number Of Employees 3.4 K
- Beta 0.31
- Market Capitalization 16.32 B
- Total Asset 6.84 B
- Retained Earnings (621.55 M)
- Working Capital 1.78 B
- Current Asset 1.09 B
- Current Liabilities 445.46 M
- Z Score 9.3
- Net Asset 6.84 B
- Accumulation Distribution 9533.37
- Daily Balance Of Power 1.060976
- Rate Of Daily Change 1.01
- Day Median Price 88.33
- Day Typical Price 88.42
- Price Action Indicator 0.72
- Period Momentum Indicator 0.87
Market Snapshot Widget Example
DAX Index Germany | 18,477 0.50 | |
Taiwan Weighted Taiwan | 20,200 0.37 | |
PSI 20 Stock Portugal | 6,277 0.88 | |
CROBEX Croatia | 2,842 0.22 | |
Budapest SE Hungary | 64,830 0.27 | |
IDX 30 Jakarta Indonesia | 503.32 0.82 | |
ISEQ 20 Price Ireland | 1,642 0.89 | |
NYSE Comp USA | 18,255 1.09 | |
Tel Aviv 35 Israel | 2,005 0.34 | |
Coreshares Index Tracker South Afric | 1,046 0.38 | |
IPC MEXICO Mexico | 57,369 0.17 | |
KL Technology Malaysia | 64.31 0.42 | |
IBEX 35 Index Spain | 11,111 1.09 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,523 0.70 | |
SPASX Dividend Opportunities Australia | 1,668 0.31 | |
HNX 30 Vietnam | 532.84 0.75 | |
Bucharest BET-NG Romania | 1,206 0.37 | |
AMS Small Cap Netherlands | 1,217 0.32 | |
Oslo Exchange Mutual Norway | 1,280 0.47 | |
BEL Small Belgium | 9,225 0.4 | |
RTSI Index Russia | 1,128 1.15 | |
Basic Materials Brazil | 6,005 1.59 | |
Swiss Leader Price Switzerland | 1,919 0.23 | |
Athens General Comp Greece | 1,418 0.35 | |
Stock Exchange Of Thailand | 1,381 0.26 | |
PX Prague Stock Czech Repub | 1,490 0.07 | |
THE PHILIPPINE STOCK Philippines | 6,904 0.08 | |
WIG 30 Poland | 2,975 0.34 | |
BIST Electricity Turkey | 536.44 0.81 |
Investing Ideas
In addition to having Biomarin Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Biomarin Pharmaceutical
Compare Biomarin Pharmaceutical To Peers
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomarin Pharmaceutical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Biomarin Stock, please use our How to Invest in Biomarin Pharmaceutical guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Biomarin Stock analysis
When running Biomarin Pharmaceutical's price analysis, check to measure Biomarin Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomarin Pharmaceutical is operating at the current time. Most of Biomarin Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Biomarin Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomarin Pharmaceutical's price. Additionally, you may evaluate how the addition of Biomarin Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |
Is Biomarin Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomarin Pharmaceutical. If investors know Biomarin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomarin Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biomarin Pharmaceutical is measured differently than its book value, which is the value of Biomarin that is recorded on the company's balance sheet. Investors also form their own opinion of Biomarin Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biomarin Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomarin Pharmaceutical's market value can be influenced by many factors that don't directly affect Biomarin Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomarin Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomarin Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomarin Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.